Hyatt targets 11-16% Adj. EBITDA CAGR through 2028, adds $1B to buyback

Hyatt Hotels Corp

2028 illustrative outlook: Adj. EBITDA $1.4B-$1.585B (11-16% CAGR); Adj. FCF $775M-$875M (14-18% CAGR).
Gross fees CAGR 9-13% to $1.545B-$1.71B; net rooms growth 6-8% CAGR through 2028.
Board authorized $1B additional share repurchase, bringing total authorization to ~$1.5B.
Reaffirmed 2026 fiscal year outlook (from April 30, 2026) including 2025 base figures.
Strategy driven by premium positioning, asset-light model, and global footprint expansion.

item 7.01 item 9.01 item 8.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-26-067209
form_type: 8-K
ticker: H
cik: 0001468174
company_name: Hyatt Hotels Corp
filed_at: 2026-05-28T10:46:19+00:00
discovered_at: 2026-05-28T10:50:00.224438+00:00
generated_at: 2026-05-28T10:50:47.402111+00:00
sec_items: ["7.01", "9.01", "8.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-26-067209
json_url: https://secwatch.observer/filing/0001104659-26-067209.json
markdown_url: https://secwatch.observer/filing/0001104659-26-067209.md
text_url: https://secwatch.observer/filing/0001104659-26-067209.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1468174/000110465926067209/0001104659-26-067209-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1468174/000110465926067209/tm2615108d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

DBX

Dropbox secures $400M revolving credit facility, authorizes $900M share repurchase program

DROPBOX, INC. June 1, 2026, 9:06 AM ET other_material Items 1.01, 2.03, 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

NXTC

NextCure Phase 1 SIM0505 data: 55% ORR in gynecologic cancers; cash into Q1 2027

NextCure, Inc. June 1, 2026, 8:10 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

JBIO

Jade Biosciences reports Phase 1 interim data: JADE101 shows ~70% IgA reduction, favorable safety, differentiated PK

Jade Biosciences, Inc. June 1, 2026, 7:55 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

EIKN

Eikon reports 63.1% ORR in Phase 2 NSCLC trial of EIK1001; PARP1 inhibitor EIK1003 shows 24.5% ORR with paclitaxel

Eikon Therapeutics, Inc. June 1, 2026, 7:30 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

MDAI

Spectral AI gets FDA clearance for DeepView burn indication; targets first commercial sales by year-end 2026

Spectral AI, Inc. June 1, 2026, 4:01 PM ET other_material Items 5.07, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

LIXT

Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board

LIXTE BIOTECHNOLOGY HOLDINGS, INC. June 1, 2026, 8:55 AM ET other_material Items 5.02, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

BMNR

Bitmine holds 5.42M ETH (4.49% of supply); total crypto + cash = $11.6B

BITMINE IMMERSION TECHNOLOGIES, INC. June 1, 2026, 8:45 AM ET other_material Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

TTRX

Turn Therapeutics GX-03 Phase 2 interim: 92.6% EASI-50 at 4 weeks; no SAEs

Turn Therapeutics Inc. June 1, 2026, 8:45 AM ET other_material Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001104659-26-067209

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.